A few thoughts today as our wacky world has gone off the reservation in terms of wackiness, so let’s get right to it
Dexcom has a blowout quarter increases revenue guidance so naturally the stock sinks almost 5.5%. Now we get that some long time Dexcom investors are taking profits and honestly, we can’t blame them given the how shares have skyrocketed over the past year or so. And we do get concerns over upcoming tougher quarterly comparisons and we somewhat understand concerns over the coming of the Libre 2. Still these concerns are overblown when you . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.